Home › Cirrhosis › Michigan
Cirrhosis clinical trials in Michigan
3 studies for Cirrhosis are looking for participants at sites in Michigan.
LIVERAGEâ„¢: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Clinical Research Institute of Michigan, LLC, Clinton Township
- West Michigan Clinical Research Center, Wyoming
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06632444Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- University of Michigan, Ann Arbor
- Henry Ford Health System, Detroit
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.